Retraction notice to Integrating Generative AI Into Evidence Synthesis: Opportunities, Safeguards, and Methodological Refinements: [JVAL Volume 29, June 2026, 4609] [0.03%]
关于“将生成式人工智能融入证据综合：机遇、保障措施和方法论完善”的撤稿声明：[JVAL 第 29 卷，2026年6月, 4609]
Weihao Cheng,Hangyu Zhu,Yuanyuan Lian
Weihao Cheng
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This letter has been retracted at the request of the Editors-in-Chief. The undisclosed use of ar...
Health-Related Quality of Life and Utility Values in Chinese Patients with Non-Small-Cell Lung Cancer: A Multicenter Study [0.03%]
中国非小细胞肺癌患者的生命质量及效用值评估：多中心研究
Luying Wang,Xin Guan,Yue Wang et al.
Luying Wang et al.
Objectives: Despite the growing interest in cost-effectiveness analysis in China, evidence to support robust economic evaluation remains limited. This study aimed to assess health-related quality of life (HRQoL) in Chines...
Systematic Review of Health Economic Evaluations of Oral Nutritional Supplement Interventions in Older Adults: An ISPOR Special Interest Group Report [0.03%]
口服营养补充干预的健康经济评价系统性回顾：ISPOR专题兴趣组报告
Amarsinh Desai,Olivia M Dong,Samuel C Z Gautier et al.
Amarsinh Desai et al.
Objective: This systematic literature review synthesizes findings from health economic evaluations in older adults receiving oral nutrition supplement (ONS) interventions. ...
Economic Evaluation of Mindfulness-Oriented Recovery Enhancement for the Treatment of Opioid Misuse [0.03%]
正念导向康复增强治疗 opioid 成瘾的经济效益评估
Fernando A Wilson,Eric L Garland
Fernando A Wilson
Objective: Opioid misuse exacts a tremendous toll on society. Mindfulness-Oriented Recovery Enhancement (MORE) is an efficacious treatment for opioid misuse. Yet, the cost-effectiveness of this intervention remains unknow...
Short Bowel Syndrome with Intestinal Failure: Healthcare Resource Utilization and Cost of Care in a Large US Claims Database [0.03%]
短肠综合征伴肠道功能衰竭：一项大型美国索赔数据库的医疗资源利用和护理成本研究
Ahan Ali,Dejan Micic,Mark Gallivan et al.
Ahan Ali et al.
Objectives: This retrospective, real-world analysis aimed to evaluate healthcare resource utilization (HCRU) and associated costs for patients with short bowel syndrome with intestinal failure (SBS-IF), who are dependent ...
Longitudinal Modeling and Simulation of Growth Hormone Efficacy in Children With Idiopathic Short Stature [0.03%]
生长激素对特发性身材矮小儿童疗效的纵向模拟与建模
Hyojin Cho,Hyeseon Jeon,Chaeri Kang et al.
Hyojin Cho et al.
Objectives: Growth hormone (GH) has been widely used to treat idiopathic short stature (ISS), defined as a height that falls below the third percentile or 2 standard deviations below the mean for age and sex. This study a...
Utilizing Large Language Models to Enhance Patient-Reported Outcome Measures: Application to the EQ-5D-5L and Bolt-ons [0.03%]
利用大型语言模型改进患者报告结果测量：在EQ-5D-5L和附加模块中的应用
Jan M Heijdra Suasnabar,Marieke van Buchem,Mathieu F Jansen et al.
Jan M Heijdra Suasnabar et al.
Objectives: Large language models (LLMs) may be useful tools for the development/adaptation of patient-reported outcome measures (PROMs). As a methodological proof-of-concept, we evaluated the use of LLMs to support the i...
Relationships between clinician-confirmed symptomatic progression and change in patient-reported outcomes in NSCLC [0.03%]
NSCLC患者临床确认的症状进展与患者报告结果变化之间的关系
James S McGinley,Andrea Savord,R J Wirth et al.
James S McGinley et al.
Objectives: Time to symptomatic progression (TTSP) is a novel endpoint used in cancer clinical trials. It is of scientific interest to understand the relationship between clinician-confirmed symptomatic progression and pa...
Impact of preventive treatment on healthcare use: a modelling study of statin treatment [0.03%]
他汀类预防用药对医疗保健利用的影响：模型研究
Junwen Zhou,Runguo Wu,Claire Williams et al.
Junwen Zhou et al.
Objectives: Statin treatment's efficacy, safety and cost-effectiveness are well accepted. We assessed statin treatment effects on primary and hospital inpatient care use. ...
Impact of Drug Shortages on Medicare Part D Prescription Drugs Inflation Rebates [0.03%]
美国医疗保险部分D中处方药短缺对通胀再补给的影响
Mariana Socal,Yuchen Wang,Jeromie Ballreich et al.
Mariana Socal et al.
Objectives: The Inflation Reduction Act requires drugs whose prices rise faster than inflation to pay a rebate to Medicare Part D, with a waiver for drugs in shortage. This study estimates, as a pre-implementation baselin...